Related Experiment Video
Updated: Dec 24, 2025

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Aptamer-functionalized DNA microgels: a strategy towards selective anticancer therapeutic systems
Yitong Wang1, Miaomiao Yan, Lu Xu
1Key Laboratory of Colloid and Interface Chemistry & Key Laboratory of Special Aggregated Materials, Shandong University, Ministry of Education, Jinan 250100, P. R. China. jhao@sdu.edu.cn.
Researchers developed novel DNA microgels for targeted cancer therapy. These biocompatible microgels selectively kill cancer cells using stimuli-responsive drug delivery, showing great potential for advanced cancer treatments.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Nanotechnology
- Drug Delivery Systems
Background:
- Conventional drug delivery systems often lack specificity, leading to off-target effects.
- Stimuli-responsive materials offer enhanced control over drug release.
- DNA nanotechnology provides precise structural control and programmability.
Purpose of the Study:
- To construct novel DNA microgels for targeted cancer therapy.
- To investigate the stimuli-responsive drug delivery capabilities of aptamer-functionalized microgels.
- To evaluate the biocompatibility and cancer cell-killing efficacy of the developed system.
Main Methods:
- DNA microgels were synthesized using DNA complementarity and photo-initiated free radical polymerization.
- Copolymers of N-isopropylacrylamide and acrylamide formed the microgel network, crosslinked by DNA.
- Aptamer-functionalized moieties were incorporated for targeted delivery and stimuli-responsiveness.
Main Results:
- Novel DNA microgels with a non-conventional structure were successfully constructed.
- The AptMG-Dox system exhibited excellent biocompatibility.
- Highly selective killing efficacy against target cancer cells was demonstrated, driven by stimuli-responsiveness.
Conclusions:
- The developed DNA microgels offer a promising platform for intelligent drug delivery.
- The aptamer-functionalized system shows significant potential for targeted cancer therapy.
- Stimuli-responsive drug release enhances therapeutic efficacy and minimizes side effects.
More Related Videos
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
08:35Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...